p53 loss and point mutations are associated with suppression of apoptosis and progression of CML into myeloid blastic crisis
- 1 October 1997
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 98 (1) , 28-35
- https://doi.org/10.1016/s0165-4608(96)00413-x
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- p53-Dependent apoptosis suppresses tumor growth and progression in vivoCell, 1994
- Apoptosis (the 1992 Frank Rose Memorial Lecture)British Journal of Cancer, 1993
- Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6Nature, 1991
- The p53 tumour suppressor geneNature, 1991
- A study of prognostic factors in blast crisis of Philadelphia chromosome‐positive chronic myelogenous leukaemiaBritish Journal of Haematology, 1990
- Rearrangement and expression of p53 in the chronic phase and blast crisis of chronic myelogenous leukemiaBlood, 1990
- Rearrangements in the p53 gene in Philadelphia chromosome positive chronic myelogenous leukemia [see comments]Blood, 1989
- Localization of gene for human p53 tumour antigen to band 17p13Nature, 1986
- Fused transcript of abl and bcr genes in chronic myelogenous leukaemiaNature, 1985
- Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22Cell, 1984